Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01126021 · ClinicalTrials.gov registry record · Phase 2

Using Technology to Promote Mental Acuity

A Phase 2 study, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 2
Development phase
600
Enrollment target

NCT01126021: Completed Phase 2 study, sponsored by University of Pennsylvania.

NCT01126021 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 600 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (351% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01126021, a Phase 2 study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 2
Development phase
600 participants
Enrollment target

Study Summary

The study plans to test the effectiveness of behavioral economics based incentives to promote the daily use of computer programs designed to improve memory and mental acuity. Subjects will be recruited from the Pittsburgh metropolitan area. The primary objective is to determine the impact of structured financial incentives on the number of computer-based cognitive exercises completed during a 3 month intervention period.

Primary Outcome

The number of memory and cognition enhancement activities played per day using the study provided software will be measured.

Interventions

  • BEHAVIORAL Financial incentives
  • BEHAVIORAL No incentives

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2010-05
Est. Completion 2012-03
Phase Phase 2
University of Pennsylvania

1,423 total trials

What the finished NCT01126021 record still lists

NCT01126021 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (351% higher).

The record links to 0 conditions, and to 2 interventions - of which Financial incentives is the first listed.

NCT01126021 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01126021 about?

NCT01126021 is a clinical study titled "Using Technology to Promote Mental Acuity". The study plans to test the effectiveness of behavioral economics based incentives to promote the daily use of computer programs designed to improve memory and mental acuity. Subjects will be recruited from the Pittsburgh metropolitan area. The primary objective is to determine the impact of structu...

What is the current status of trial NCT01126021?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 600 participants. The study started on 2010-05. Estimated completion is 2012-03.

What interventions are being tested in trial NCT01126021?

The interventions under investigation include: Financial incentives (BEHAVIORAL), No incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT01126021?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01126021's enrollment target sits among peer trials

600 53rd of 2000 higher than 1,945 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01126021, the US trial registry maintained by the National Library of Medicine. NCT01126021 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.